MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, KNSA made $214,266K in revenue. $21,952K in net income. Net profit margin of 10.25%.

Income Overview

Revenue
$214,266K
Net Income
$21,952K
Net Profit Margin
10.25%
EPS
$0.27
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • GB

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
214,266 171,088* 180,855 156,797
Cost of goods sold
20,796 19,383* 20,257 18,603
Collaboration expenses
75,577 55,958* 63,307 52,418
Research and development
27,475 32,475* 24,166 18,753
Selling, general and administrative
61,151 52,322* 49,104 46,863
Total operating expenses
184,999 160,137* 156,834 136,637
Income (loss) from operations
29,267 10,951* 24,021 20,160
Other income
3,414 2,868* 3,136 2,717
Income (loss) before income taxes
32,681 13,818* 27,157 22,877
Provision for income taxes
10,089 9,213* 8,722 5,045
Net income (loss)
22,592 4,605* 18,435 17,832
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax
-640 123 -102 112
Total other comprehensive income (loss)
-640 123* -102 112
Total comprehensive income (loss)
21,952 4,728 18,333 17,944
Basic EPS
0.3 0.063 0.25 0.24
Diluted EPS
0.27 0.06 0.23 0.23
Basic Average Shares
76,516,535 74,449,396 74,714,846 73,438,530
Diluted Average Shares
82,409,703 78,959,608 80,035,400 77,942,082
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
US$214,068K GB$198K Revenue$214,266K Income (loss) fromoperations$29,267K Other income$3,414K Total operatingexpenses$184,999K Income (loss) beforeincome taxes$32,681K Collaboration expenses$75,577K Selling, general andadministrative$61,151K Research and development$27,475K Cost of goods sold$20,796K Net income (loss)$22,592K Provision for income taxes$10,089K Total comprehensiveincome (loss)$21,952K Total othercomprehensive income (loss)-$640K Unrealized gain (loss) onshort-term investments and...-$640K

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals International, plc (KNSA)